These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

440 related articles for article (PubMed ID: 36016180)

  • 21. Late inflammatory reactions in patients with soft tissue fillers after SARS-CoV-2 infection and vaccination: A systematic review of the literature.
    Bachour Y; Bekkenk MW; Rustemeyer T; Kadouch JA
    J Cosmet Dermatol; 2022 Apr; 21(4):1361-1368. PubMed ID: 35150192
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Acute kidney rejection after anti-SARS-CoV-2 virus-vectored vaccine-case report.
    Vnučák M; Graňák K; Beliančinová M; Jeseňák M; Macháleková KK; Benko J; Samoš M; Dedinská I
    NPJ Vaccines; 2022 Mar; 7(1):30. PubMed ID: 35236844
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A systematic review of cases of CNS demyelination following COVID-19 vaccination.
    Ismail II; Salama S
    J Neuroimmunol; 2022 Jan; 362():577765. PubMed ID: 34839149
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Safety and humoral response rate of inactivated and mRNA vaccines against SARS-CoV-2 in patients with Multiple Sclerosis.
    Ciampi E; Uribe-San-Martin R; Soler B; García L; Guzman J; Pelayo C; Jürgensen L; Guzman I; Vera F; Galleguillos L; Cárcamo C
    Mult Scler Relat Disord; 2022 Mar; 59():103690. PubMed ID: 35182880
    [TBL] [Abstract][Full Text] [Related]  

  • 25. T cell repertoire profiling in allografts and native tissues in recipients with COVID-19 after solid organ transplantation: Insight into T cell-mediated allograft protection from viral infection.
    Fu J; Rust D; Fang Z; Jiao W; Lagana S; Batal I; Chen B; Merl S; Jones R; Sykes M; Weiner J
    Front Immunol; 2022; 13():1056703. PubMed ID: 36591281
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Immunogenicity and Risk Factors Associated With Poor Humoral Immune Response of SARS-CoV-2 Vaccines in Recipients of Solid Organ Transplant: A Systematic Review and Meta-Analysis.
    Manothummetha K; Chuleerarux N; Sanguankeo A; Kates OS; Hirankarn N; Thongkam A; Dioverti-Prono MV; Torvorapanit P; Langsiri N; Worasilchai N; Moonla C; Plongla R; Garneau WM; Chindamporn A; Nissaisorakarn P; Thaniyavarn T; Nematollahi S; Permpalung N
    JAMA Netw Open; 2022 Apr; 5(4):e226822. PubMed ID: 35412626
    [TBL] [Abstract][Full Text] [Related]  

  • 27. COVID-19 vaccination and corneal allograft rejection- a review.
    Allen NE; Zhang J; McGhee CNJ
    Front Cell Infect Microbiol; 2023; 13():1307655. PubMed ID: 38162575
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pooled rates and demographics of POTS following SARS-CoV-2 infection versus COVID-19 vaccination: Systematic review and meta-analysis.
    Yong SJ; Halim A; Liu S; Halim M; Alshehri AA; Alshahrani MA; Alshahrani MM; Alfaraj AH; Alburaiky LM; Khamis F; Muzaheed ; AlShehail BM; Alfaresi M; Al Azmi R; Albayat H; Al Kaabi NA; Alhajri M; Al Amri KAS; Alsalman J; Algosaibi SA; Al Fares MA; Almanaa TN; Almutawif YA; Mohapatra RK; Rabaan AA
    Auton Neurosci; 2023 Dec; 250():103132. PubMed ID: 38000119
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pilot Findings on SARS-CoV-2 Vaccine-Induced Pituitary Diseases: A Mini Review from Diagnosis to Pathophysiology.
    Taieb A; Mounira EE
    Vaccines (Basel); 2022 Nov; 10(12):. PubMed ID: 36560413
    [TBL] [Abstract][Full Text] [Related]  

  • 30. COVID-19 and Immune-Mediated RBC Destruction.
    Jacobs JW; Booth GS
    Am J Clin Pathol; 2022 Jun; 157(6):844-851. PubMed ID: 34919640
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Investigation of Humoral and Cellular Immunity in TOBB ETÜ Hospital Workers After Three Doses of CoronaVac Vaccination and after One Dose of Comirnaty Vaccination Following Two Doses of CoronaVac].
    Özyurda F; Ardıçoğlu Akışın Y; Mert T; Poyraz B; Özkan Y; Turan M; Göçmen JS; Yücel A; Akar N
    Mikrobiyol Bul; 2022 Jul; 56(3):387-403. PubMed ID: 35960233
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Update on COVID-19 vaccination in pediatric solid organ transplant recipients.
    Dulek DE; Ardura MI; Green M; Michaels MG; Chaudhuri A; Vasquez L; Danziger-Isakov L; Posfay-Barbe KM; McCulloch MI; L'Huillier AG; Benden C
    Pediatr Transplant; 2022 Aug; 26(5):e14235. PubMed ID: 35060251
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A randomized, double-blind, placebo-controlled phase III clinical trial to evaluate the efficacy and safety of SARS-CoV-2 vaccine (inactivated, Vero cell): a structured summary of a study protocol for a randomised controlled trial.
    Akova M; Unal S
    Trials; 2021 Apr; 22(1):276. PubMed ID: 33849629
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Myocarditis in SARS-CoV-2 infection vs. COVID-19 vaccination: A systematic review and meta-analysis.
    Voleti N; Reddy SP; Ssentongo P
    Front Cardiovasc Med; 2022; 9():951314. PubMed ID: 36105535
    [TBL] [Abstract][Full Text] [Related]  

  • 35. SARS-CoV-2 and chronic myeloid leukemia: a systematic review.
    Ali EA; Al-Sadi A; Al-Maharmeh Q; Subahi EA; Bellamkonda A; Kalavar M; Panigrahi K; Alshurafa A; Yassin MA
    Front Med (Lausanne); 2023; 10():1280271. PubMed ID: 38327268
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Decreasing neutralization antibody levels following vaccination against SARS-CoV-2 in the elderly: an observational study in Southern Moravia, Czech Republic.
    Mravčík V; Husa P; Kumpanová Valachovičová S; Vobořil J
    Epidemiol Mikrobiol Imunol; 2022; 71(1):9-20. PubMed ID: 35477266
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Safety of SARS-CoV-2 vaccination in patients with Behcet's syndrome and familial Mediterranean fever: a cross-sectional comparative study on the effects of M-RNA based and inactivated vaccine.
    Ozdede A; Guner S; Ozcifci G; Yurttas B; Toker Dincer Z; Atli Z; Uygunoğlu U; Durmaz E; Uçar D; Uğurlu S; Saip S; Tabak F; Hamuryudan V; Seyahi E
    Rheumatol Int; 2022 Jun; 42(6):973-987. PubMed ID: 35376962
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Short-term immune response after inactivated SARS-CoV-2 (CoronaVac®, Sinovac) and ChAdOx1 nCoV-19 (Vaxzevria®, Oxford-AstraZeneca) vaccinations in health care workers.
    Jantarabenjakul W; Chantasrisawad N; Puthanakit T; Wacharapluesadee S; Hirankarn N; Ruenjaiman V; Paitoonpong L; Suwanpimolkul G; Torvorapanit P; Pradit R; Sophonphan J; Putcharoen O
    Asian Pac J Allergy Immunol; 2022 Sep; 40(3):269-277. PubMed ID: 34717527
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Differences in Antibody Responses Between an Inactivated SARS-CoV-2 Vaccine and the BNT162b2 mRNA Vaccine in Solid-Organ Transplant Recipients.
    Erol Ç; Yanık Yalçın T; Sarı N; Bayraktar N; Ayvazoğlu Soy E; Yavuz Çolak M; Azap Ö; Arslan H; Haberal M
    Exp Clin Transplant; 2021 Dec; 19(12):1334-1340. PubMed ID: 34951350
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Antibodies Against SARS-CoV-2 in Human Breast Milk After Vaccination: A Systematic Review and Meta-Analysis.
    Whited N; Cervantes J
    Breastfeed Med; 2022 Jun; 17(6):475-483. PubMed ID: 35325550
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.